LACOSAMIDE
Body System:
Manner of administration:Oral
Restriction (Streamlined authority code: 17515)
Indication: Idiopathic generalised epilepsy with primary generalised tonic-clonic seizures
Treatment phase: Dose titration at the start of therapy, during therapy or to gradually cease treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 14 | # of repeats: 1 | DPMQ: $26.07 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
Body System:
Manner of administration:Oral
Restriction (Streamlined authority code: 17541)
Indication: Intractable focal onset seizures
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 14 | # of repeats: 1 | DPMQ: $26.07 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||